Ultrafast and Parts-per-Billion-Level MEMS Gas Sensors by Hetero-Interface Engineering of 2D/2D Cu-TCPP@ZnIn2S4 with Enriched Surface Sulfur Vacancies.

The primary challenge for resonant-gravimetric gas sensors is the synchronous improvement of the sensitivity and response time, which is restricted by low adsorption capacity and slow mass transfer in the sensing process and remains a great challenge. In this study, a novel 2D/2D Cu-TCPP@ZnIn2S4 composite is successfully constructed, in which Cu-TCPP MOF is used as a core substrate for the growth of 2D ultrathin ZnIn2S4 nanosheets with well-defined {0001} crystalline facets. The Cu-TCPP@ZnIn2S4 sensor exhibited high sensitivity (1.5 Hz@50 and 2.3 Hz@100 ppb), limit of detection (LOD: 50 ppb), and ultrafast (9 s @500 ppb) detection of triethylamine (TEA), which is the lowest LOD and the fastest sensor among the reported TEA sensors at room temperature, tackling the bottleneck for the ultrafast detection of the resonant-gravimetric sensor. These above results provide an innovative and easily achievable pathway for the synthesis of heterogeneous structure sensing materials.

Optical Temperature-Sensing Performance of La2Ce2O7:Ho3+ Yb3+ Powders.

In this paper, La2Ce2O7 powders co-activated by Ho3+ and Yb3+ were synthesized by a high temperature solid-state reaction. Both Ho3+ and Yb3+ substitute the La3+ sites in the La2Ce2O7 lattice, where the Ho3+ concentration is 0.5 at.% and the Yb3+ concentration varies in the range of 10~18% at.%. Pumped by a 980 nm laser, the up-conversion (UC) green emission peak at 547 nm and the red emission at 661 nm were detected. When the doping concentration of Ho3+ and Yb3+ are 0.5 at.% and 14% at.%, respectively, the UC emission reaches the strongest intensity. The temperature-sensing performance of La2Ce2O7:Ho3+ with Yb3+ was studied in the temperature range of 303-483 K, where the highest relative sensitivity (Sr) is 0.0129 K-1 at 483 K. The results show that the powder La2Ce2O7:Ho3+, Yb3+ can be a potential candidate for remote temperature sensors.

Broadband short-wave near-infrared-emitting phosphor MgNb2O6:Cr3+ for pc-LED applications.

Broadband short-wave near-infrared (NIR) phosphor-converted light-emitting diodes (pc-LEDs) have been attracting keen interest for miniature NIR spectroscopy, while still lacking sufficient novel broadband NIR-emitting phosphors. Herein, we report a novel MgNb2O6:Cr3+ polycrystalline phosphor with a broad NIR emission band centered at 970 nm and a large full-width at half-maximum of approximately 155 nm under excitation of bluish-green light at around 515 nm. The optimized phosphor MgNb2O6:1%Cr3+ features a high internal quantum efficiency (IQE) of ∼85.5% and a moderate external QE of 25.2%. The fluorescence properties determined by two distorted hexa-coordination octahedral sites (i.e. [MgO6] and [NbO6]), low crystal field strength (Dq/B ∼ 1.65), and Cr3+-doping concentration were systematically investigated for comprehensive understanding of photophysical mechanisms. Besides, this broadband NIR phosphor MgNb2O6:Cr3+ exhibits a moderate thermal quenching of 21.4%@373 K for pc-LED application. An NIR pc-LED self-built by combining the optimal phosphor with a commercial cyan of ∼515 nm exhibits an NIR output power increase from 3.19 to 11.38 mW as the drive current is varied from 40 to 220 mA. With the help of this prototype pc-LED device, multiple applications were successfully performed to clearly recognize blood vessel distributions in the human finger, penetrate a plastic cap, and distinguish multi-color text. Undoubtedly, further development of such broadband short-wave NIR-emitting phosphors will make novel pc-LED devices for significant applications in biomedical imaging, nondestructive safety detection, intelligent identification, etc.

UVB upconversion of LiYO2:Ho3+,Gd3+ for application in luminescence thermometry.

Development of novel ultraviolet (UV) upconversion materials has been emerging as a hot research topic for application in tunable UV lasers, photocatalysis, sterilization, tagging, and most recently luminescence thermometry. We readily synthesized a series of Ho3+/Gd3+ co-doped LiYO2 upconversion phosphors by a traditional high-temperature reaction. Under excitation from a blue ∼445 nm laser, LiYO2:Ho3+,Gd3+ polycrystalline powders yield intense sharp ultraviolet B (UVB) upconversion luminescence from Gd3+ 6Pj (j = 7/2, 5/2, 3/2) excited states. By means of steady and dynamic photoluminescence spectra, we systematically investigated the involved two-photon absorption upconversion as well as the accompanying energy transfer processes between Ho3+ and Gd3+ ions in the LiYO2 host lattice. Interestingly, the distinguishable UVB luminescence constituents from Gd3+ 6Pj excited states exhibit sensitive temperature dependence in a 353-673 K range. Shedding light on thermal equilibria between Gd3+ 6Pj UV-emitting levels, their luminescence intensity ratios follow Boltzmann statistics for the application of new luminescence thermometry. For the scheme of 6P7/2-6P3/2 thermally coupled levels, it works over a temperature range of 373-673 K with a maximum relative sensitivity (Sr) of about 1.07% K-1 at 373 K, and its 6P7/2-6P5/2 counterpart works over 353-533 K with a maximum Sr of about 0.83% K-1 at 353 K. Overall, our study provides a new pathway to develop UV upconversion materials, and promotes the application of Gd3+-related UV luminescence constituents in sensitive temperature sensing over a wide temperature range.

Construction of an La-BiVO4/O-Doped g-C3N4 Heterojunction Photocatalyst Embedded in Electrospinning Nanofibers.

BiVO4 has been widely used in the field of photocatalysis due to its nontoxic and moderate band gap. However, single BiVO4 has the disadvantages of a high recombination rate of photogenerated carriers and weak response to visible light, inhibiting its photocatalytic applications. To explore viable solutions, a hybrid material composed of lanthanum-doped bismuth vanadate (La-BiVO4) and oxygen-doped porous graphite carbon nitride (O-doped g-C3N4), i.e., La-BiVO4/O-doped g-C3N4 powder, was prepared by a facile hydrothermal reaction and low-temperature calcination. Then, the powder was loaded on polyacrylonitrile nanofibers (NFs) through the electrospinning fiber technique. Various surface science characterizations, including transmission electron microscopy and nitrogen absorption and desorption analysis, confirmed the successful synthesis of a mesoporous heterojunction material. The La3+-doping as well as the porous morphologies and larger specific surface area of the O-doped g-C3N4 ultimately improve the photocatalytic abilities via a proposed Z-scheme heterojunction mechanism. The roles of La3+-doping and morphology modification in promoting the separation of the photogenerated carriers and broadening the optical absorption range were experimentally discussed. The RhB degradation experiment indicated that the La-BiVO4/O-doped g-C3N4 powder has excellent photocatalytic activity, which is about 2.85 and 2 times higher than that of the pure BiVO4 and O-doped g-C3N4, respectively. Meanwhile, the La-BiVO4/O-doped g-C3N4 NF shows good stability and recoverability after a 10-cycle testing. Such a hybrid photocatalyst with a proposed Z-scheme heterojunction mechanism and good plasticity might pave a feasible way to fabricate a new library of photocatalysts.

Electrospun Membranes Anchored with g-C3N4/MoS2 for Highly Efficient Photocatalytic Degradation of Aflatoxin B1 under Visible Light.

The degradation of aflatoxin (AF) is a topic that always exists along with the food and feed industry. Photocatalytic degradation as an advanced oxidation technology has many benefits, including complete inorganic degradation, no secondary contamination, ease of activity under moderate conditions, and low cost compared with traditional physical, chemical, and biological strategies. However, photocatalysts are usually dispersed during photocatalytic reactions, resulting in energy and time consumption in the separation process. There is even a potential secondary pollution problem from the perspective of food safety. In this regard, three electrospun membranes anchored with g-C3N4/MoS2 composites were prepared for highly efficient photocatalytic degradation of aflatoxin B1 (AFB1) under visible light. These photocatalytic membranes were characterized by XRD, SEM, TEM, FTIR, and XPS. The factors influencing the degradation efficiency of AFB1, including pH values and initial concentrations, were also probed. The three kinds of photocatalytic membranes all exhibited excellent ability to degrade AFB1. Among them, the photocatalytic degradation efficiency of the photocatalytic membranes prepared by the coaxial methods reached 96.8%. The experiment is with an initial concentration of 0.5 µg/mL (500 PPb) after 60 min under visible light irradiation. The mechanism of degradation of AFB1 was also proposed based on active species trapping experiments. Moreover, the prepared photocatalytic membranes exhibited excellent photocatalytic activity even after five-fold use in the degradation of AFB1. These studies showed that electrospun membranes anchored with g-C3N4/MoS2 composites have a high photocatalytic ability which is easily removed from the reacted medium for reuse. Thereby, our study offers a highly effective, economical, and green solution for AFB1 degradation in the foodstuff for practical application.

Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapy.

Antiangiogenesis therapies targeting vascular endothelial growth factor (VEGF) have revolutionized the treatment of neovascular ocular diseases, including neovascular age-related macular degeneration (nAMD). Compelling evidence has implicated the vital role of complement system dysregulation in AMD pathogenesis, implying it as a potential therapeutic strategy for geographic atrophy in dry AMD and to enhance the efficacy of anti-VEGF monotherapies in nAMD. This study reports the preclinical assessment and phase 1 clinical outcomes of a bispecific fusion protein, efdamrofusp alfa (code: IBI302), which is capable of neutralizing both VEGF isoforms and C3b/C4b. Efdamrofusp alfa showed superior efficacy over anti-VEGF monotherapy in a mouse laser-induced choroidal neovascularization (CNV) model after intravitreal delivery. Dual inhibition of VEGF and the complement activation was found to further inhibit macrophage infiltration and M2 macrophage polarization. Intravitreal efdamrofusp alfa demonstrated favorable safety profiles and exhibited antiangiogenetic efficacy in a nonhuman primate laser-induced CNV model. A phase 1 dose-escalating clinical trial (NCT03814291) was thus conducted on the basis of the preclinical data. Preliminary results showed that efdamrofusp alfa was well tolerated in patients with nAMD. These data suggest that efdamrofusp alfa might be effective for treating nAMD and possibly other complement-related ocular conditions.

One ion to catch them all: Targeted high-precision Boltzmann thermometry over a wide temperature range with Gd3.

Ratiometric luminescence thermometry with trivalent lanthanide ions and their 4fn energy levels is an emerging technique for non-invasive remote temperature sensing with high spatial and temporal resolution. Conventional ratiometric luminescence thermometry often relies on thermal coupling between two closely lying energy levels governed by Boltzmann's law. Despite its simplicity, Boltzmann thermometry with two excited levels allows precise temperature sensing, but only within a limited temperature range. While low temperatures slow down the nonradiative transitions required to generate a measurable population in the higher excitation level, temperatures that are too high favour equalized populations of the two excited levels, at the expense of low relative thermal sensitivity. In this work, we extend the concept of Boltzmann thermometry to more than two excited levels and provide quantitative guidelines that link the choice of energy gaps between multiple excited states to the performance in different temperature windows. By this approach, it is possible to retain the high relative sensitivity and precision of the temperature measurement over a wide temperature range within the same system. We demonstrate this concept using YAl3(BO3)4 (YAB):Pr3+, Gd3+ with an excited 6PJ crystal field and spin-orbit split levels of Gd3+ in the UV range to avoid a thermal black body background even at the highest temperatures. This phosphor is easily excitable with inexpensive and powerful blue LEDs at 450 nm. Zero-background luminescence thermometry is realized by using blue-to-UV energy transfer upconversion with the Pr3+-Gd3+ couple upon excitation in the visible range. This method allows us to cover a temperature window between 30 and 800 K.

Dexamethasone enhances the lung metastasis of breast cancer via a PI3K-SGK1-CTGF pathway.

Dexamethasone (Dex), as a pretreatment agent, is widely used to attenuate the side effects of chemotherapy in breast cancer treatment. However, whether and how Dex affects breast cancer metastasis remain to be furtherly understood. In this study, we established several mouse breast cancer metastatic models to study the effect of Dex in vitro and in vivo. Transwell, Western Blot and RNA interference were applied to study the molecular mechanism of Dex in promoting breast cancer cell migration. Meanwhile, the effect of Dex on lung metastasis of breast cancer in Dex combined with PTX chemotherapy was discussed. Our results confirmed that Dex could promote breast cancer cell metastasis both in vitro and in vivo. Mechanistic studies revealed that this pro-metastatic effect of Dex was mediated by the GR-PI3K-SGK1-CTGF pathway in tumor cells. Ligation of Dex and glucocorticoid receptor (GR) on tumor cells activated the PI3K signaling pathway and upregulated serum glucocorticoid-inducible kinase 1 (SGK1) expression, and then increased the expression of connective tissue growth factor (CTGF) through Nedd4l-Smad2. Moreover, Dex was the leading factor for lung metastasis in a standard regimen for breast cancer treatment with paclitaxel and Dex. Importantly, targeting SGK1 with the inhibitor GSK650394 remarkably reduced lung metastasis in this regimen. Our present data provide new insights into Dex-induced breast cancer metastasis and indicate that SGK1 could be a candidate target for the treatment of breast cancer metastasis.

Protective Effect of a Bispecific Fc-Fusion Protein on the Barrier of Human Retinal Pigment Epithelial Cells.

INTRODUCTION: The aim of the study was to evaluate the protective effects of IBI302, a bispecific Fc-fusion protein that theoretically can bind vascular endothelial growth factor (VEGF), complement C3b, and C4b in the barrier of the cultured human retinal pigment epithelial (hRPE) cells. METHODS: Primary hRPE cells were isolated and cultured to monolayer barrier. hRPE monolayers were divided into the PBS control group, VEGF-Trap group, complement receptor 1 (CR1) group, and IBI302 group. Identification of hRPE cells, barrier function, inflammation factors, and immune response products was tested by immunofluorescent staining, transepithelial resistance (TER), and ELISA. RESULTS: IBI302 treatment significantly improved the TER of the barrier of hRPE cells after complement-activated oxidative stress compared with the PBS control group, VEGF-Trap group, and CR1 group. The maximum effect of IBI302 on protecting hRPE cell viability was observed at the concentration of 1 µg/mL. The elevated expression of VEGF, chemokine (C-C Motif) ligand 2, C3a, C5a, and membrane attack complex was reduced by IBI302. CONCLUSION: IBI302 could protect the barrier function of hRPE cells. IBI302 might be a potentially effective drug for the RPE barrier-associated ocular diseases.

BATF2 prevents glioblastoma multiforme progression by inhibiting recruitment of myeloid-derived suppressor cells.

The basic leucine zipper ATF-like transcription factor 2 (BATF2) has been implicated in inflammatory responses and anti-tumour effects. Little, however, is known regarding its extracellular role in maintaining a non-supportive cancer microenvironment. Here, we show that BATF2 inhibits glioma growth and myeloid-derived suppressor cells (MDSCs) recruitment. Interestingly, extracellular vesicles (EVs) from BATF2-overexpressing glioma cell lines (BATF2-EVs) inhibited MDSCs chemotaxis in vitro. Moreover, BATF2 inhibited intracellular SDF-1α and contributes to decreased SDF-1α in EVs. In addition, BATF2 downregulation-induced MDSCs recruitment were reversed by blocking SDF-1α/CXCR4 signalling upon AMD3100 treatment. Specifically, detection of EVs in 24 pairs of gliomas and healthy donors at different stages revealed that the abundance of BATF2-positive EVs in plasma (BATF2+ plEVs) can distinguish stage III-IV glioma from stage I-II glioma and healthy donors. Taken together, our study identified novel regulatory functions of BATF2 in regulating MDSCs recruitment, providing a prognostic value in terms of the number of BATF2+ plEVs in glioma stage.

Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.

Paclitaxel (PTX) has shown pleiotropic immunologic effects on the tumor microenvironment, and nanomicelle has emerged as a promising strategy for PTX delivery. However, the detailed mechanisms remain to be fully elucidated. Meanwhile, immunogenic cell death (ICD) is an effective approach to activate the immune system. This study investigated the ICD effect of PTX and how nanomicelle affected the immune-activation ability of PTX. Methods: The ICD effects of PTX were identified via the expression of ICD markers and cell vaccine experiment. Tumor size and overall survival in multiple animal models with treatment were monitored to evaluate the antitumor effects. The mechanisms of PTX-induced ICD and antitumor immunity were determined by detecting gene expression related to ER stress and analyzing immune cell profile in tumor after treatment. Results: We revealed the immune-regulation mechanism of PTX nanomicelle by inducing ICD, which can promote antigen presentation by dendritic cells (DCs) and activate antitumor immunity. Notably, nanomicelle encapsulation protected the ICD effects and immune activation, which were hampered by immune system impairment caused by chemotherapy. Compared with traditional formulations, a low dose of nanomicelle-encapsulated PTX (nano-PTX) treatment induced immune-dependent tumor control, which increased the infiltration and function of both T cells and DCs within tumors. However, this antitumor immunity was hampered by highly expressed PD-1 on tumor-infiltrating CD8+ T cells and upregulated PD-L1 on both immune cells and tumor cells after nano-PTX treatment. Combination therapy with a low dose of nano-PTX and PD-1 antibodies elicited CD8+ T cell-dependent antitumor immunity and remarkably improved the therapeutic efficacy. Conclusions: Our results provide systemic insights into the immune-regulation ability of PTX to induce ICD, which acts as an inducer of endogenous vaccines through ICD effects, and also provides an experimental basis for clinical combination therapy with nano-PTX and PD-1 antibodies.

Understanding and tuning blue-to-near-infrared photon cutting by the Tm3+/Yb3+ couple.

Lanthanide-based photon-cutting phosphors absorb high-energy photons and 'cut' them into multiple smaller excitation quanta. These quanta are subsequently emitted, resulting in photon-conversion efficiencies exceeding unity. The photon-cutting process relies on energy transfer between optically active lanthanide ions doped in the phosphor. However, it is not always easy to determine, let alone predict, which energy-transfer mechanisms are operative in a particular phosphor. This makes the identification and design of new promising photon-cutting phosphors difficult. Here we unravel the possibility of using the Tm3+/Yb3+ lanthanide couple for photon cutting. We compare the performance of this couple in four different host materials. Cooperative energy transfer from Tm3+ to Yb3+ would enable blue-to-near-infrared conversion with 200% efficiency. However, we identify phonon-assisted cross-relaxation as the dominant Tm3+-to-Yb3+ energy-transfer mechanism in YBO3, YAG, and Y2O3. In NaYF4, in contrast, the low maximum phonon energy renders phonon-assisted cross-relaxation impossible, making the desired cooperative mechanism the dominant energy-transfer pathway. Our work demonstrates that previous claims of high photon-cutting efficiencies obtained with the Tm3+/Yb3+ couple must be interpreted with care. Nevertheless, the Tm3+/Yb3+ couple is potentially promising, but the host material-more specifically, its maximum phonon energy-has a critical effect on the energy-transfer mechanisms and thereby on the photon-cutting performance.

A Novel Antitumor Strategy: Simultaneously Inhibiting Angiogenesis and Complement by Targeting VEGFA/PIGF and C3b/C4b.

Therapeutic antibodies targeting vascular endothelial growth factor (VEGF) have become a critical regimen for tumor therapy, but the efficacy of monotherapy is usually limited by drug resistance and multiple angiogenic mechanisms. Complement proteins are becoming potential candidates for cancer-targeted therapy based on their role in promoting cancer progression and angiogenesis. However, the antitumor abilities of simultaneous VEGF and complement blockade were unknown. We generated a humanized soluble VEGFR-Fc fusion protein (VID) binding VEGFA/PIGF and a CR1-Fc fusion protein (CID) targeting C3b/C4b. Both VID and CID had good affinities to their ligands and showed effective bioactivities. In vitro, angiogenesis effects induced by VEGF and hemolysis induced by complement were inhibited by VID and CID, respectively. Further, VID and CID confer a synergetic therapeutic effect in a colitis-associated colorectal cancer (CAC) model and an orthotopic 4T1 breast cancer model. Mechanically, combination therapy inhibited tumor angiogenesis, cell proliferation, and MDSC infiltration in the tumor microenvironment and promoted tumor cell apoptosis. Our study offers a novel therapeutic strategy for anti-VEGF-resistant tumors and chronic-inflammation-associated tumors.

Correction to: Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects.

Following publication of the original article [1], the authors reported an error in Fig 5 of this article, graphs presenting FCM and immunofluorescent for CD4T, CD8T and NK cell of the Control Groups (LL2, LL2-irradation, MCS-irradiation) were inadvertently duplicated from another parallel experiment.